JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
474 * | Wed, 8/3/2011, 8:30 AM - 10:20 AM | CC-D234 | |
Issues in Vaccines — Contributed Papers | |||
Biopharmaceutical Section , Scientific and Public Affairs Advisory Committee | |||
Chair(s): Ghideon Ghebregiorgis, U.S. Food and Drug Administration | |||
8:35 AM | An Alternative to ANCOVA When Standard Assumptions Are Untenable — J. Brooke Marshall, Merck Research Laboratories ; Devan V. Mehrotra, Merck Research Laboratories | ||
8:50 AM | Threshold Methods for Immunological Correlates of Protection — Andrew Dunning, Sanofi-Pasteur ; Xuan Chen, Sanofi-Pasteur ; Huiling Xiong, Sanofi Pasteur ; Fabrice Bailleux, Sanofi-Pasteur ; Li Qin, Fred Hutchinson Cancer Research Center ; Kamal Desai, University of London | ||
9:05 AM | Evaluation of Immune Response (gpELISA) as the Principal Surrogate Endpoint for Protection of Herpes Zoster Afforded by Zostavax — Xiaoming Li, Merck Research Laboratories ; Xiaopeng Miao, Boston University ; Ivan S. F. Chan, Merck Research Laboratories | ||
9:20 AM | Comparison of TLOVR Algorithm Versus Snapshot Approach for HIV Studies — Wei Zhang, Boehringer Ingelheim ; Michael Pannucci, Boehringer Ingelheim ; Junhai Guo, Boehringer Ingelheim ; David Hall, Boehringer Ingelheim | ||
9:35 AM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.